Couverture de GLP-1 Drugs and Sleep Apnea — A Breakthrough?

GLP-1 Drugs and Sleep Apnea — A Breakthrough?

GLP-1 Drugs and Sleep Apnea — A Breakthrough?

De : Inception Point Ai
Écouter gratuitement

À propos de ce contenu audio

 Host Julia Cartwright explores how GLP-1 weight loss drugs are revolutionizing obstructive sleep apnea treatment, following tirzepatide's groundbreaking FDA approval. From clinical trial results to biological mechanisms and access barriers, this series examines whether these drugs offer real hope beyond the CPAP machine for millions of Americans.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai
Épisodes
  • GLP-1 Drugs and Sleep Apnea — A Breakthrough? - The Trial That Changed Everything

    GLP-1 Drugs and Sleep Apnea — A Breakthrough? - The Trial That Changed Everything
    Apr 7 2026
    Julia Cartwright explores how tirzepatide (Zepbound) became the first FDA-approved medication for obstructive sleep apnea in adults with obesity. She examines the groundbreaking SURMOUNT-OSA trials, which showed dramatic reductions in breathing disruptions and achieved disease remission in up to 50% of participants, offering new hope beyond CPAP machines.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Afficher plus Afficher moins
    26 min
Aucun commentaire pour le moment